SCHEMBL3626752

SCHEMBL3626752

COc1ccc2c(c1)OC(=O)NC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.49
PDE3A Q14432 1/20 0.49
EGFR P00533 3/20 0.46
CA2 P00918 1/20 0.44
CA5A P35218 1/20 0.44
AURKA O14965 4/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
METAP1 P53582 2/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31166766 0.79 RAB9A (0.46) NPC1RAB9AACHE
SCHEMBL14368234 0.78 PARP10 (0.41) CA12CA9METAP1ALDH1A1MAPT
SCHEMBL5738880 0.77 GAA (0.61) PDE3BPDE3AEGFRCA2CA5A
SCHEMBL11247777 0.77 ADRA2A (0.48) CA2CA12CA9ALDH1A1KDM4E
SCHEMBL14495775 0.75 CA12 (0.54) CA2CA5ACA12CA9METAP1
SCHEMBL30950383 0.75 PARP1 (0.41) EGFRMAPTACHEMAOB
SCHEMBL31525565 0.75 CA12 (0.54) CA2CA5ACA12CA9METAP1
SCHEMBL2768150 0.75 CA2 (0.40) CA2CA5AAURKAALDH1A1KDM4E
SCHEMBL13369130 0.74 PARP1 (0.41) ALDH1A1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL9399922 0.74 EGFR (0.44) PDE3BPDE3AEGFRCA2CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795251-B2 3,4-dihydro-benzo[e][1,3]oxazin-2-ones NOVARTIS AG (CH) 2010-09-14 US disclosed
EP-1874742-A1 3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES Novartis AG (CH) 2008-01-09 EP disclosed
WO-2006108671-A1 3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES NOVARTIS AG (CH) 2006-10-19 WO disclosed